ArticleOrphanet journal of rare diseases2019

Evaluation of neurofibromatosis type 1 progression using a nationwide registry of patients who submitted claims for medical expense subsidies in Japan between 2008 and 2012.

Takashi Yamauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.